A detailed history of Cetera Investment Advisers transactions in Incyte Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 11,994 shares of INCY stock, worth $860,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,994
Previous 12,836 6.56%
Holding current value
$860,209
Previous $778,000 1.8%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $48,271 - $57,769
-842 Reduced 6.56%
11,994 $792,000
Q2 2024

Aug 22, 2024

BUY
$51.18 - $63.75 $172,783 - $215,220
3,376 Added 35.69%
12,836 $778,000
Q1 2024

May 24, 2024

BUY
$56.55 - $66.59 $534,963 - $629,941
9,460 New
9,460 $538,000
Q4 2023

Feb 13, 2024

SELL
$52.16 - $64.19 $22,689 - $27,922
-435 Reduced 7.21%
5,602 $351,000
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $577 - $659
10 Added 0.17%
6,037 $348,000
Q2 2023

Aug 09, 2023

SELL
$60.95 - $75.51 $6,887 - $8,532
-113 Reduced 1.84%
6,027 $375,000
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $77,182 - $94,524
-1,099 Reduced 15.18%
6,140 $443,000
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $20,892 - $26,158
311 Added 4.49%
7,239 $581,000
Q3 2022

Nov 10, 2022

SELL
$66.18 - $82.86 $11,118 - $13,920
-168 Reduced 2.37%
6,928 $462,000
Q2 2022

Aug 11, 2022

BUY
$66.18 - $83.18 $109,660 - $137,829
1,657 Added 30.47%
7,096 $539,000
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $113,818 - $137,420
1,724 Added 46.41%
5,439 $432,000
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $32,050 - $37,499
-506 Reduced 11.99%
3,715 $273,000
Q3 2021

Nov 16, 2021

SELL
$68.67 - $84.02 $1,236 - $1,512
-18 Reduced 0.42%
4,221 $290,000
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $399 - $437
-5 Reduced 0.12%
4,239 $357,000
Q1 2021

May 17, 2021

SELL
$76.02 - $100.5 $9,426 - $12,462
-124 Reduced 2.84%
4,244 $345,000
Q4 2020

Feb 17, 2021

BUY
$80.74 - $97.7 $352,672 - $426,753
4,368 New
4,368 $380,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.